INTELLECTUAL PROPERTY AND PATENTS. 27.1 Intellectual property consists of inventions, publications, computer software, courseware, works of art and music, data bases, lecture notes, laboratory manuals, articles, books, as well as all other creations that can be protected under patent, copyright, trademark or similar laws.
INTELLECTUAL PROPERTY AND PATENTS. 2.5.1 Both the supervisor and student are aware that intellectual property, including data generated during postgraduate research and study, belongs to Stellenbosch University, according to the SU IP policy. Copies of all data (raw and analysed) must be submitted to the supervisor on completion of the study (General Policies and Rules: Calendar Part 1) (In case of any IP related queries please contact Innovus).
INTELLECTUAL PROPERTY AND PATENTS. (a) Xxxxxx will retain and own all right, title and interest in and to any intellectual property (x) that Xxxxxx owned or had rights to before the date of the order subject to these General Terms and/or (y) on Goods that result from use of Buyer’s designs, specifications or instructions. Consequently, by submitting designs, specifications or instructions to Xxxxxx, Buyer irrevocably agrees that Xxxxxx shall be free to use the same, free of charge, and in the broadest possible manner (and not only to manufacture Goods for Buyer), for the entire period of protection afforded to intellectual property rights (including any extension thereof) which could cover Buyer’s designs, specifications or instructions. To the extent any aspects of any Goods resulting from the use of Buyer’s designs, specifications or instructions is not automatically the exclusive property of Safran, Buyer hereby irrevocably assigns to Safran, on an exclusive basis, free of charge, all right, title and interest in and to any intellectual property on any such Goods, allowing Xxxxxx to use and exploit the same in any part of the world and for the entire duration of protection of said intellectual property rights, including in particular the exclusive right to exploit, reproduce, present, adapt, modify, translate, distribute, license, sell, market and use the same, in the broadest possible manner, for the entire period of protection afforded to intellectual property rights (including any extension thereof). Such assignment is made without limitation as to the number of reproductions or presentations that may be made, in all countries and in all languages, by all means of exploitation and on all current or future types of media, including computer media, multimedia, networks, including the internet, and by direct or satellite broadcasting. The sale of Goods (including if manufactured according to Buyer’s designs, specifications or instructions) or any parts thereof hereunder confers on Buyer no license under any patent or other intellectual property rights of Safran covering or relating inter alia to (i) the structure of any devices to which the Goods or parts may be applied or (ii) a process or machine in connection with which they may be used, and does not allow Buyer to create or develop derivatives works or products from the Goods thereafter.
INTELLECTUAL PROPERTY AND PATENTS. (a) Intellectual Property (“IP”) means all copyright and all rights in relation to inventions (including patent rights), registered and unregistered trademarks (including service marks), registered and unregistered designs, circuit layouts, and any other rights resulting from intellectual activity in the industrial, scientific, literary and artistic fields recognised in domestic law anywhere in the world.
INTELLECTUAL PROPERTY AND PATENTS. (a) Safran will retain and own all right, title and interest in and to any intellectual property (x) that Safran owned or had rights to before the date of the order subject to these General Terms and/or (y) on Goods that result from use of Buyer’s designs, specifications or instructions. Consequently, by submitting designs, specifications or instructions to Safran, Buyer irrevocably agrees that Safran shall be free to use the same, free of charge, and in the broadest possible manner (and not only to manufacture Goods for Buyer), for the entire period of protection afforded to intellectual property rights (including any extension thereof) which could cover Buyer’s procesadores) sin la autorización previa y expresa por escrito de la otra parte. Ninguna de las partes copiará, almacenará o transferirá a otros países los Datos Personales sin la autorización previa y expresa por escrito de la otra parte.
INTELLECTUAL PROPERTY AND PATENTS. 2.1. The Employee undertakes to immediately bring to Teva’s attention or the attention of whoever is designated by Teva, all Confidential Information or other information, created, developed or which came to Employee’s attention and which relates to Teva’s field of operations, including any improvement, invention, innovation, process, creation, discovery, formula, technique, conclusions, knowledge, findings, research results, examination or experiment, developments, designs, ideas, etc., whether or not patentable or eligible to be protected as another proprietary right, whether or not forming the subject-matter of an application for registration of the right, whether or not it constitutes a service invention in accordance with the law, which were made, conceived, produced or implemented, developed or formed, in whole or in part, by the Employee alone or jointly with others, in Israel or abroad, during the Term of Employment at Teva or in connection with the Employee’s work at Teva (hereinafter, jointly and severally: “Information Created by the Employee”). For the avoidance of any doubt, it is hereby clarified that Information Created by the Employee will include, inter alia, information created, formed or developed after the commencement of the Term of Employment (even if conceived or developed prior to the execution of this Letter of Undertaking) and/or after termination thereof, provided that the information relates, directly or indirectly, to the Employee’s work and/or employment with Teva
INTELLECTUAL PROPERTY AND PATENTS. 8.1 Patent ownership. Syngenta shall own the entire right, title, and interest in and to all Patent Rights and shall have the exclusive right to apply for, seek issuance of, and maintain or abandon any or all of Syngenta's Patent Rights.
INTELLECTUAL PROPERTY AND PATENTS. 9.1 Inventorship shall be determined according to United States Patent law.
INTELLECTUAL PROPERTY AND PATENTS. ImmunoClin, Ltd’s intellectual property and patents are including, but are not limited to, the following: All intellectual property created by ImmunoClin, Ltd and All patents filed, in-process, or contemplated by ImmunoClin, Ltd. Patent Title Applicant (s) / country Filing date HIGH THROUGHPUT DETERMINATION OF ANTIGEN EXPRESSION IMMUNOCLIN LABORATORIES LIMITED (United Kingdom) 27.11.2000 ASSAY METHOD FOR EVALUATING CELL RESPONSES TO INFECTION IMMUNOCLIN LABORATORIES LIMITED (United Kingdom) 01.11.2000 TREATMENT WITH CYTOKINES FOR ALZHEIMER'S DISEASE IMMUNOCLIN, LTD. (United Kingdom) 31.05.2002 MARKER GENE IMMUNOCLIN, LTD. (United Kingdom) OSAKA INDUSTRIAL PROMOTION ORGANISATION (JAPAN) 16.10.2002 BIOMARKERS OF RESISTANCE TO INFECTIONS IN HUMANS AND BIOLOGICAL APPLICATION THEREOF (IL-22) INSTITUT DE RECHERCHE POUR LE DEVELOPPEMENT (IRD) (France) IMMUNOCLIN, LTD. (United Kingdom) 5.11.2003
INTELLECTUAL PROPERTY AND PATENTS. Objective Objective 2: Rationalisation of the regional structures that operate in the promotion of research, technology transfer and the development of innovation Strand of activity 2.1: Definition and implementation, in collaboration with the Friuli Venezia Giulia Autonomous Region and the MUR, of an organisational model of Innovation Enablers Description of the intervention Development of a regional Patent and Competitive Intelligence hub through strengthening of collaborations between the Area Science Park PatLib Centre and SiS Partners for research, analysis and strategic management of technical and scientific information and patents to support technological-transfer activity, with particular focus on protection, management and promotion of Intellectual Property. More specifically, the intention is to establish channels and methods of interaction making it possible to support System Partners, both structurally and on demand, with the performance of studies and analyses aimed at identifying the applications potential of the results of research, with purposes all along the chain of processes for technological transfer, from protection of new discoveries to their commercialisation. Implementing bodies Area Science Park Starting date 2021 Planned duration Multi-year Planned expenditure SiS FVG 2021/2022/2023 Funds (partially covering operating costs, personnel and database, of the Area Science Park PatLib Centre) Output indicator • Development of an organisational model enabling systematization at the regional level of expertise and resources dedicated to promoting research • Identification of applications and industrial potential of results of research through studies and analyses into the relevant technological and patent scenario • Support for definition of strategies to protect Intellectual Property in terms of the results of research and evaluation of possibilities for extension, maintenance and continuation of industrial property rights • Identification of directions for development of innovations also through selection of potential industrial partners to involve in utilisation and commercialisation of the results of research. Result indicator The first year of the programme (December 2021–April 2022) was dedicated to planning of the system supporting activities for protection, management and promotion of Intellectual Property performed by SiS FVG Partners • Number of agreements with SiS FVG Partners (at least 4 in the first year) • Number of awarene...
